These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7537117)

  • 1. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.
    Laï JL; Zandecki M; Mary JY; Bernardi F; Izydorczyk V; Flactif M; Morel P; Jouet JP; Bauters F; Facon T
    Blood; 1995 May; 85(9):2490-7. PubMed ID: 7537117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.
    Facon T; Lai JL; Nataf E; Preudhomme C; Zandecki M; Hammad M; Wattel E; Jouet JP; Bauters F
    Br J Haematol; 1993 Aug; 84(4):743-5. PubMed ID: 8217836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
    Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
    Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques.
    Smadja NV; Louvet C; Isnard F; Dutel JL; Grange MJ; Varette C; Krulik M
    Br J Haematol; 1995 Jul; 90(3):619-24. PubMed ID: 7647003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases.
    Hernández JM; Gutiérrez NC; Almeida J; García JL; Sánchez MA; Mateo G; Ríos A; San Miguel JF
    Br J Haematol; 1998 Oct; 103(1):163-7. PubMed ID: 9792304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells.
    Zhang XG; Bataille R; Jourdan M; Saeland S; Banchereau J; Mannoni P; Klein B
    Blood; 1990 Dec; 76(12):2599-605. PubMed ID: 2265252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of SCF, IL-6, IL-3, and GM-CSF increases the mitotic index in short term bone marrow cultures from acute promyelocytic leukemia (APL) patients.
    Williams B; Allan DJ
    Cancer Genet Cytogenet; 1996 Oct; 91(1):77-81. PubMed ID: 8908173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO; Schneider JG; Moore MA
    Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Effect of Improved Culturing Method on the Detection Rate of Chromosome Karyotyping in Multiple Myeloma].
    Wang N; Fan KK; Yuan LJ; Jin HS; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1129-1133. PubMed ID: 35981372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic study of multiple myeloma].
    Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
    Oh S; Koo DH; Kwon MJ; Kim K; Suh C; Min CK; Yoon SS; Shin HJ; Jo DY; Kwak JY; Kim JS; Sohn SK; Joo YD; Eom HS; Kim SH; Kim YS; Kim C; Mun YC; Kim H; Lee DS; Lee JH;
    Ann Hematol; 2014 Aug; 93(8):1353-61. PubMed ID: 24671365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
    Witzig TE; Gertz MA; Lust JA; Kyle RA; O'Fallon WM; Greipp PR
    Blood; 1996 Sep; 88(5):1780-7. PubMed ID: 8781435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil maturation of CD34+ cells from peripheral blood and bone marrow in serum-free culture medium with PIXY321 and granulocyte-colony stimulating factor (G-CSF).
    Smith SL; Bender JG; Berger C; Lee WJ; Loudovaris M; Martinson JA; Opotowsky JD; Qiao X; Schneidkraut M; Sweeney P; Unverzagt KL; Van Epps DE; Williams DE; Williams SF; Zimmerman TM
    J Hematother; 1997 Aug; 6(4):323-34. PubMed ID: 9377071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-kit ligand (SCF) in human multiple myeloma cells.
    Lemoli RM; Fortuna A
    Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
    Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
    Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.